Multi-Peptide Blends · Research deep dive
Wolverine Blend (BPC-157 / TB-500): the cited literature
Every study referenced in the Wolverine Blend (BPC-157 / TB-500) monograph, with plain-language context, PubMed links to read each paper yourself, and how the compound appears in the dosing literature.
How this compound is studied
Across the dosing literature, Wolverine Blend (BPC-157 / TB-500) is studied at 500 mcg – 1 mg per administration, typically once daily (combined peptide mass). The reference walkthrough below maps each citation to what it actually showed.
References covered
BPC 157 and tissue protection
Curr. Pharm. Des., 2018
Thymosin β4 in wound healing
Ann. N.Y. Acad. Sci., 2012
The full walkthrough is for subscribers
Unlock the evidence grading, what each study actually found, how the trials dosed it, reported safety signals, open questions, and PubMed links for Wolverine Blend (BPC-157 / TB-500).